{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:04:50Z","timestamp":1784340290578,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Basic Science Research Program through the NRF funded by the Ministry of Education","award":["2022R1I1A01064295"],"award-info":[{"award-number":["2022R1I1A01064295"]}]},{"name":"Korean Fund for Regenerative Medicine funded by the Ministry of Science and ICT, and Ministry of Health and Welfare","award":["23A0201L1"],"award-info":[{"award-number":["23A0201L1"]}]},{"name":"Korean Fund for Regenerative Medicine funded by the Ministry of Science and ICT, and Ministry of Health and Welfare","award":["25A0204L1"],"award-info":[{"award-number":["25A0204L1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s13770-025-00753-6","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T14:25:28Z","timestamp":1756909528000},"page":"1159-1172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human Mesenchymal Stem Cell-Derived Skeletal Muscle Cell Spheroids for Treating Dexamethasone-Induced Sarcopenia"],"prefix":"10.1007","volume":"22","author":[{"given":"Yoonji","family":"Yum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Hwa","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Chul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-3911","authenticated-orcid":false,"given":"Saeyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"753_CR1","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393:2636\u201346.","journal-title":"Lancet"},{"key":"753_CR2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","volume":"22","author":"E Dent","year":"2018","unstructured":"Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22:1148\u201361.","journal-title":"J Nutr Health Aging."},{"key":"753_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.688526","volume":"12","author":"T Gustafsson","year":"2021","unstructured":"Gustafsson T, Ulfhake B. Sarcopenia: what is the origin of this aging-induced disorder? Front Genet. 2021;12: 688526.","journal-title":"Front Genet"},{"key":"753_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/nu12051293","volume":"12","author":"SK Papadopoulou","year":"2020","unstructured":"Papadopoulou SK. Sarcopenia: a contemporary health problem among older adult populations. Nutrients. 2020;12:1293.","journal-title":"Nutrients"},{"key":"753_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.maturitas.2015.08.006","volume":"82","author":"HE Senior","year":"2015","unstructured":"Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JW. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas. 2015;82:418\u201323.","journal-title":"Maturitas"},{"key":"753_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/jcsm.13160","volume":"14","author":"LD Westbury","year":"2023","unstructured":"Westbury LD, Beaudart C, Bruy\u00e8re O, Cauley JA, Cawthon P, Cruz-Jentoft AJ, et al. Recent sarcopenia definitions-prevalence, agreement and mortality associations among men: findings from population-based cohorts. J Cachexia Sarcopenia Muscle. 2023;14:565\u201375.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"753_CR7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jcsm.12483","volume":"10","author":"J Bauer","year":"2019","unstructured":"Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle. 2019;10:956\u201361.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"753_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/jcsm.12607","volume":"11","author":"TH Chen","year":"2020","unstructured":"Chen TH. Comment on: \u201cMyostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy\u201d by Zhou et al. J Cachexia Sarcopenia Muscle. 2020;11:1377\u20138.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"753_CR9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2169\/internalmedicine.55.6298","volume":"55","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Nishiguchi S. Sarcopenia and sarcopenic obesity are prognostic factors for overall survival in patients with cirrhosis. Intern Med. 2016;55:855\u20136.","journal-title":"Intern Med"},{"key":"753_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jbspin.2018.08.001","volume":"86","author":"A Tournadre","year":"2019","unstructured":"Tournadre A, Vial G, Capel F, Soubrier M, Boirie Y. Sarcopenia. Joint Bone Spine. 2019;86:309\u201314.","journal-title":"Joint Bone Spine"},{"key":"753_CR11","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/jcsm.13104","volume":"13","author":"N Cacciani","year":"2022","unstructured":"Cacciani N, Sk\u00e4rl\u00e9n \u00c5, Wen Y, Zhang X, Addinsall AB, Llano-Diez M, et al. A prospective clinical study on the mechanisms underlying critical illness myopathy-a time-course approach. J Cachexia Sarcopenia Muscle. 2022;13:2669\u201382.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"753_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00134-022-06819-6","volume":"48","author":"WD Schweickert","year":"2022","unstructured":"Schweickert WD, Patel BK, Kress JP. Timing of early mobilization to optimize outcomes in mechanically ventilated ICU patients. Intensive Care Med. 2022;48:1305\u20137.","journal-title":"Intensive Care Med"},{"key":"753_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.20836","volume":"3","author":"D Rooks","year":"2020","unstructured":"Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, et al. Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw Open. 2020;3: e2020836.","journal-title":"JAMA Netw Open"},{"key":"753_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174995","volume":"925","author":"A Yadav","year":"2022","unstructured":"Yadav A, Yadav SS, Singh S, Dabur R. Natural products: potential therapeutic agents to prevent skeletal muscle atrophy. Eur J Pharmacol. 2022;925: 174995.","journal-title":"Eur J Pharmacol"},{"key":"753_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-030-80038-3_14","volume-title":"Sarcopenia: Research and Clinical Implications","author":"MB Zazzara","year":"2021","unstructured":"Zazzara MB, Penfold RS, Onder G. The Future of Drugs in Sarcopenia. In: Veronese N, Beaudart C, Sabico S, editors. Sarcopenia: Research and Clinical Implications. Switzerland: Springer Cham; 2021. p. 181\u2013208."},{"key":"753_CR16","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e146","volume":"37","author":"MR Cho","year":"2022","unstructured":"Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci. 2022;37: e146.","journal-title":"J Korean Med Sci"},{"key":"753_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12272-024-01493-2","volume":"47","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Feng J, Yu Y, Ling M, Wang X. Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies. Arch Pharm Res. 2024;47:301\u201324.","journal-title":"Arch Pharm Res"},{"key":"753_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084300","volume":"25","author":"A Najm","year":"2024","unstructured":"Najm A, Niculescu AG, Grumezescu AM, Beuran M. Emerging therapeutic strategies in sarcopenia: an updated review on pathogenesis and treatment advances. Int J Mol Sci. 2024;25: 4300.","journal-title":"Int J Mol Sci"},{"key":"753_CR19","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.14336\/AD.2023.0210","volume":"14","author":"X Tian","year":"2023","unstructured":"Tian X, Pan M, Zhou M, Tang Q, Chen M, Hong W, Zhao F, Liu K. Mitochondria transplantation from stem cells for mitigating sarcopenia. Aging Dis. 2023;14:1700.","journal-title":"Aging Dis"},{"key":"753_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.18632\/aging.203830","volume":"14","author":"M Haroon","year":"2022","unstructured":"Haroon M, Boers HE, Bakker AD, Bloks NGC, Hoogaars WMH, et al. Reduced growth rate of aged muscle stem cells is associated with impaired mechanosensitivity. Aging (Albany NY). 2022;14:28\u201353.","journal-title":"Aging (Albany NY)"},{"key":"753_CR21","first-page":"429","volume":"44","author":"RSY Wong","year":"2022","unstructured":"Wong RSY, Cheong SK. Therapeutic potential of mesenchymal stem cells and their derivatives in sarcopenia. Malays J Pathol. 2022;44:429\u201342.","journal-title":"Malays J Pathol"},{"key":"753_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41419-023-05843-8","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Zhao B, Zhai J, Wang A, Cao N, Liao T, Su R, He L, Li Y, Pei X, Jia Y, Yue W. Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice. Cell Death Dis. 2023;14:321.","journal-title":"Cell Death Dis"},{"key":"753_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13287-023-03418-0","volume":"14","author":"BY Wang","year":"2023","unstructured":"Wang BY, Hsiao AW, Shiu HT, Wong N, Wang AY, Lee CW, Lee OK, Lee WY. Mesenchymal stem cells alleviate dexamethasone-induced muscle atrophy in mice and the involvement of ERK1\/2 signalling pathway. Stem Cell Res Ther. 2023;14:195.","journal-title":"Stem Cell Res Ther"},{"key":"753_CR24","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/stem.3058","volume":"37","author":"SY Oh","year":"2019","unstructured":"Oh SY, Choi YM, Kim HY, Park YS, Jung SC, Park JW, et al. Application of tonsil-derived mesenchymal stem cells in tissue regeneration: concise review. Stem Cells. 2019;37:1252\u201360.","journal-title":"Stem Cells"},{"key":"753_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3892\/ijmm.2016.2536","volume":"37","author":"S Park","year":"2016","unstructured":"Park S, Choi Y, Jung N, Yu Y, Ryu KH, Kim HS, et al. Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration. Int J Mol Med. 2016;37:1209\u201320.","journal-title":"Int J Mol Med"},{"key":"753_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s13770-022-00489-7","volume":"19","author":"S Park","year":"2022","unstructured":"Park S, Jeong S, Nam YH, Yum Y, Jung SC. Transplantation of differentiated tonsil-derived mesenchymal stem cells ameliorates murine Duchenne muscular dystrophy via autophagy activation. Tissue Eng Regen Med. 2022;19:1283\u201394.","journal-title":"Tissue Eng Regen Med"},{"key":"753_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/mus.27847","volume":"68","author":"Y Choi","year":"2023","unstructured":"Choi Y, Nam YH, Jeong S, Lee HY, Choi SY, Park S, Jung SC. Biochemical and functional characterization of skeletal muscle cells differentiated from tonsil-derived mesenchymal stem cells. Muscle Nerve. 2023;68:219\u201329.","journal-title":"Muscle Nerve"},{"key":"753_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00441-011-1215-5","volume":"347","author":"PR Baraniak","year":"2012","unstructured":"Baraniak PR, McDevitt TC. Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential. Cell Tissue Res. 2012;347:701\u201311.","journal-title":"Cell Tissue Res"},{"key":"753_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.biomaterials.2018.02.049","volume":"165","author":"YB Lee","year":"2018","unstructured":"Lee YB, Kim EM, Byun H, Chang HK, Jeong K, Aman ZM, et al. Engineering spheroids potentiating cell-cell and cell-ECM interactions by self-assembly of stem cell microlayer. Biomaterials. 2018;165:105\u201320.","journal-title":"Biomaterials"},{"key":"753_CR30","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1073\/pnas.1008117107","volume":"107","author":"TJ Bartosh","year":"2010","unstructured":"Bartosh TJ, Yl\u00f6stalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3d spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A. 2010;107:13724\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"753_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12195-020-00624-1","volume":"13","author":"RR Besser","year":"2020","unstructured":"Besser RR, Bowles AC, Alassaf A, Carbonero D, Maciel R, Saporta M, Agarwal A. A chemically defined common medium for culture of C2C12 skeletal muscle and human induced pluripotent stem cell derived spinal spheroids. Cell Mol Bioeng. 2020;13:605\u201319.","journal-title":"Cell Mol Bioeng"},{"key":"753_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jot.2022.11.005","volume":"39","author":"BY Wang","year":"2022","unstructured":"Wang BY, Hsiao AW, Wong N, Chen YF, Lee CW, Lee WYW. Is dexamethasone-induced muscle atrophy an alternative model for naturally aged sarcopenia model? J Orthop Translat. 2022;39:12\u201320.","journal-title":"J Orthop Translat"},{"key":"753_CR33","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1021\/acsbiomaterials.2c00026","volume":"8","author":"VS Madamsetty","year":"2022","unstructured":"Madamsetty VS, Mohammadinejad R, Uzieliene I, Nabavi N, Dehshahri A, Garc\u00eda-Couce J, et al. DEXamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems. ACS Biomater Sci Eng. 2022;8:1763\u201390.","journal-title":"ACS Biomater Sci Eng"},{"key":"753_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/antiox12030639","volume":"12","author":"YS Hah","year":"2023","unstructured":"Hah YS, Lee WK, Lee SJ, Lee SY, Seo JH, Kim EJ, et al. Rutin prevents dexamethasone-induced muscle loss in C2C12 myotube and mouse model by controlling FOXO3-dependent signaling. Antioxidants. 2023;12:639.","journal-title":"Antioxidants"},{"key":"753_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jgr.2024.09.002","volume":"49","author":"A Kim","year":"2025","unstructured":"Kim A, Park SM, Kim NS, Park M, Cha SJ. Ginsenoside Rc prevents dexamethasone-induced muscle atrophy and enhances muscle strength and motor function. Ginseng Res. 2025;49:42\u201352.","journal-title":"Ginseng Res"},{"key":"753_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13395-015-0060-8","volume":"5","author":"E Latres","year":"2016","unstructured":"Latres E, Pangilinan J, Miloscio L, Bauerlein R, Na E, Potocky TB, et al. Myosta- tin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skelet Muscle. 2016;5:34.","journal-title":"Skelet Muscle"},{"key":"753_CR37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.21338","volume":"63","author":"KR Wagner","year":"2008","unstructured":"Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, et al. A phase I\/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol. 2008;63:561\u201371.","journal-title":"Ann Neurol"},{"key":"753_CR38","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","volume":"3","author":"C Becker","year":"2015","unstructured":"Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Rec-knor CP, et al. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, ran- domised, phase 2 trial. Lancet Diabetes Endocrinol. 2015;3:948\u201357.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"753_CR39","doi-asserted-by":"publisher","first-page":"14042","DOI":"10.1038\/boneres.2014.42","volume":"3","author":"DJ Digirolamo","year":"2015","unstructured":"Digirolamo DJ, Singhal V, Chang X, Lee SJ, Germain-Lee EL. Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta. Bone Res. 2015;3:14042.","journal-title":"Bone Res"},{"key":"753_CR40","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/jcsm.12472","volume":"10","author":"N Gharahdaghi","year":"2019","unstructured":"Gharahdaghi N, Rudrappa S, Brook MS, Idris I, Crossland H, Hamrock C, et al. Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men. J Cachexia Sarcopenia Muscle. 2019;10:1276\u201394.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"753_CR41","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/antiox11122358","volume":"11","author":"R Ranjit","year":"2022","unstructured":"Ranjit R, Van Remmen H, Ahn B. Acylated ghrelin receptor agonist HM01 decreases lean body and muscle mass, but unacylated ghrelin protects against redox-dependent sarcopenia. Antioxidants. 2022;11:2358.","journal-title":"Antioxidants"},{"key":"753_CR42","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1002\/cncr.32406","volume":"125","author":"S Hamauchi","year":"2019","unstructured":"Hamauchi S, Furuse J, Takano T, Munemoto Y, Furuya K, Baba H, et al. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer. 2019;125:4294\u2013302.","journal-title":"Cancer"},{"key":"753_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1089\/jmf.2020.4778","volume":"24","author":"K Varma","year":"2021","unstructured":"Varma K, Amalraj A, Divya C, Gopi S. The efficacy of the novel bioavailable curcumin (Cureit) in the management of sarcopenia in healthy elderly subjects: a randomized, placebo-controlled, double-blind clinical study. J Med Food. 2021;24:40\u20139.","journal-title":"J Med Food"},{"key":"753_CR44","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1002\/jcsm.13057","volume":"13","author":"M Bagherniya","year":"2022","unstructured":"Bagherniya M, Mahdavi A, Shokri-Mashhadi N, Banach M, Von Haehling S, Johnston TP, et al. The beneficial thera- peutic effects of plant-derived natural products for the treatment of Sarcopenia. J Cachexia Sarcopenia Muscle. 2022;13:2772\u201390.","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"753_CR45","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1016\/j.clnu.2021.06.024","volume":"40","author":"H Roschel","year":"2021","unstructured":"Roschel H, Hayashi AP, Fernandes AL, Jambassi-Filho JC, Hevia-Larra\u00edn V, De Capitani M, et al. Supplement-based nutritional strategies to tackle frailty: a multifactorial, double-blind, randomized placebo-controlled trial. Clin Nutr. 2021;40:4849\u201358.","journal-title":"Clin Nutr"},{"key":"753_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2018.05.028","volume":"58","author":"Y Yoshimura","year":"2019","unstructured":"Yoshimura Y, Bise T, Shimazu S, Tanoue M, Tomioka Y, Araki M, et al. Effects of a leu- cine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with Sarcopenia: a randomized controlled trial. Nutrition. 2019;58:1\u20136.","journal-title":"Nutrition"},{"key":"753_CR47","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.3390\/nu15163613","volume":"15","author":"T Huang","year":"2023","unstructured":"Huang T, Liu C, Cui C, Zhang N, Cheung WH, Wong RMY. Potential of fatty acids in treating sarcopenia: a systematic review. Nutrients. 2023;15:3613.","journal-title":"Nutrients"},{"key":"753_CR48","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.tim.2022.10.003","volume":"31","author":"L Mancin","year":"2023","unstructured":"Mancin L, Wu GD, Paoli A. Gut microbiota-bile acid-skeletal muscle axis. Trends Microbiol. 2023;31:254\u201369.","journal-title":"Trends Microbiol"},{"key":"753_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.18632\/aging.101358","volume":"10","author":"A Del Campo","year":"2018","unstructured":"Del Campo A, Contreras-Hern\u2019andez I, Castro-Sep\u00falveda M, Campos CA, Figueroa R, Tevy MF, et al. Muscle function decline and mitochondria changes in middle age precede sarcopenia in mice. Aging. 2018;10:34.","journal-title":"Aging"},{"key":"753_CR50","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/jcsm.12560","volume":"11","author":"GK Shang","year":"2020","unstructured":"Shang GK, Han L, Wang ZH, Liu YP, Yan SB, Sai WW, et al. Sarcopenia is attenuated by TRB3 knockout in aging mice via the alleviation of atrophy and fibrosis of skeletal muscles. J Cachexia Sarcopenia Muscle. 2020;11:1104\u201320.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"753_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8059","volume":"371","author":"A Palla","year":"2021","unstructured":"Palla A, Ravichandran M, Wang Y, Alexandrova L, Yang A, Kraft P, et al. Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science. 2021;371: eabc8059.","journal-title":"Science"},{"key":"753_CR52","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/ptj\/81.11.1810","volume":"81","author":"W Scott","year":"2001","unstructured":"Scott W, Stevens J, Binder-Macleod SA. Human skeletal muscle fiber type classifications. Phys Ther. 2001;81:1810\u20136.","journal-title":"Phys Ther"},{"key":"753_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0022-510X(88)90132-3","volume":"84","author":"J Lexell","year":"1988","unstructured":"Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84:275\u201394.","journal-title":"J Neurol Sci"},{"key":"753_CR54","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.4049\/jimmunol.174.4.2318","volume":"174","author":"K Hsu","year":"2005","unstructured":"Hsu K, Passey RJ, Endoh Y, Rahimi F, Youssef P, Yen T, et al. Regulation of S100A8 by glucocorticoids. J Immunol. 2005;174:2318\u201326.","journal-title":"J Immunol"},{"key":"753_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep01215","volume":"3","author":"WR Swindell","year":"2013","unstructured":"Swindell WR, Johnston A, Xing X, Little A, Robichaud P, Voorhees JJ, et al. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation. Sci Rep. 2013;3:1\u201313.","journal-title":"Sci Rep"},{"key":"753_CR56","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.3390\/ijms21217918","volume":"21","author":"A DeChick","year":"2020","unstructured":"DeChick A, Hetz R, Lee J, Speelman DL. Increased skeletal muscle fiber cross-sectional area, muscle phenotype shift, and altered insulin signaling in rat Hindlimb muscles in a prenatally androgenized rat model for polycystic ovary syndrome. Int J Mol Sci. 2020;21:7918.","journal-title":"Int J Mol Sci."},{"key":"753_CR57","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15917","volume":"12","author":"Y Miao","year":"2024","unstructured":"Miao Y, Xie L, Song J, Cai X, Yang J, Ma X, Chen S, Xie P. Unraveling the causes of sarcopenia: roles of neuromuscular junction impairment and mitochondrial dysfunction. Physiol Rep. 2024;12: e15917.","journal-title":"Physiol Rep"},{"key":"753_CR58","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s11357-021-00510-2","volume":"44","author":"A Moreira-Pais","year":"2022","unstructured":"Moreira-Pais A, Ferreira R, Oliveira PA, Duarte JA. A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved. Geroscience. 2022;44:1199\u2013213.","journal-title":"Geroscience"},{"key":"753_CR59","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.wneu.2024.08.076","volume":"191","author":"XG Yang","year":"2024","unstructured":"Yang XG, Guo HY, Peng Z, Luo HT, Lu S. Application of electrophysiological techniques in assessing of neuromuscular junction-related disorders. World Neurosurg. 2024;191:165\u201371.","journal-title":"World Neurosurg"},{"key":"753_CR60","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1152\/physrev.00033.2014","volume":"95","author":"LA Tintignac","year":"2015","unstructured":"Tintignac LA, Brenner HR, R\u00fcegg MA. Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting. Physiol Rev. 2015;95:809\u201352.","journal-title":"Physiol Rev"},{"key":"753_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/acel.12150","volume":"13","author":"DT Hwee","year":"2014","unstructured":"Hwee DT, Baehr LM, Philp A, Baar K, Bodine SC. Maintenance of muscle mass and load-induced growth in Muscle RING Finger 1 null mice with age. Aging Cell. 2014;13:92\u2013101.","journal-title":"Aging Cell"},{"key":"753_CR62","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nbt.2978","volume":"32","author":"SW Lane","year":"2014","unstructured":"Lane SW, Williams DA, Watt FM. Modulating the stem cell niche for tissue regeneration. Nat Biotechnol. 2014;32:795\u2013803.","journal-title":"Nat Biotechnol"},{"key":"753_CR63","first-page":"50","volume":"19","author":"W Kim","year":"2022","unstructured":"Kim W, Gwon Y, Park S, Kim H, Kim J. Therapeutic strategies of three-dimensional stem cell spheroids and organoids for tissue repair and regeneration. Bioact Mater. 2022;19:50\u201374.","journal-title":"Bioact Mater"},{"key":"753_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.actbio.2022.10.054","volume":"155","author":"MA Gionet-Gonzales","year":"2023","unstructured":"Gionet-Gonzales MA, Gresham RCH, Griffin KH, Casella A, Wohlgemuth RP, Ramos-Rodriguez DH, et al. Mesenchymal stromal cell spheroids in sulfated alginate enhance muscle regeneration. Acta Biomater. 2023;155:271\u201381.","journal-title":"Acta Biomater"},{"key":"753_CR65","doi-asserted-by":"publisher","first-page":"3606765","DOI":"10.1155\/2022\/3606765","volume":"2022","author":"A Revete","year":"2022","unstructured":"Revete A, Aparicio A, Cisterna BA, Revete J, Luis L, Ibarra E, Segura Gonz\u00e1lez EA, Molino J, Reginensi D. Advancements in the use of hydrogels for regenerative medicine: properties and biomedical applications. Int J Biomater. 2022;2022:3606765.","journal-title":"Int J Biomater"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-025-00753-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-025-00753-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-025-00753-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:02:26Z","timestamp":1763791346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-025-00753-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1007\/s13770-025-00753-6","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study protocol was approved by the Ewha Womans University Medical Center (EUMC) institutional review board (IRB number: EUMC-2021-09-036). All the experimental procedures were reviewed and approved by the ethics committee for animal research at Ewha Womans University (IACUC No. EWHA MEDIACUC 22\u2013043). Informed Consent Statement: Informed written consent was obtained from all the patients participating in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}